Glioblastoma cells inhibit astrocytic p53-expression favoring cancer malignancy

[1]  N. Cashman,et al.  A special focus issue on the materials of PRION 2013 meeting in Banff, Alberta Canada , 2014, Prion.

[2]  C. Prives,et al.  MdmX Is Required for p53 Interaction with and Full Induction of the Mdm2 Promoter after Cellular Stress , 2012, Molecular and Cellular Biology.

[3]  Milena B. Furtado,et al.  Retinoblastoma protein regulates the crosstalk between autophagy and apoptosis, and favors glioblastoma resistance to etoposide , 2013, Cell Death and Disease.

[4]  Carlos José Pereira de Lucena,et al.  Automatic embryonic stem cells detection and counting method in fluorescence microscopy images , 2009, 2009 IEEE International Symposium on Biomedical Imaging: From Nano to Macro.

[5]  Peter Olson,et al.  Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. , 2010, Cancer cell.

[6]  N. B. Viana,et al.  Gap junctions are involved in cell migration in the early postnatal subventricular zone , 2009, Developmental neurobiology.

[7]  Z. Werb,et al.  The extracellular matrix: A dynamic niche in cancer progression , 2012, The Journal of cell biology.

[8]  F. Tovar-Moll,et al.  Equinatoxin II potentiates temozolomide- and etoposide-induced glioblastoma cell death. , 2012, Current topics in medicinal chemistry.

[9]  Douglas Hanahan,et al.  Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment Prospects and Obstacles for Therapeutic Targeting of Function-enabling Stromal Cell Types , 2022 .

[10]  Joshua M. Korn,et al.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.

[11]  R. Linden,et al.  Radiation-induced apoptosis in developing mouse retina exhibits dose-dependent requirement for ATM phosphorylation of p53 , 2004, Cell Death and Differentiation.

[12]  A. Harris,et al.  Effects of acute versus chronic hypoxia on DNA damage responses and genomic instability. , 2010, Cancer research.

[13]  R. Weinberg,et al.  Tumor spectrum analysis in p53-mutant mice , 1994, Current Biology.

[14]  Robert D. Cardiff,et al.  Selective Evolution of Stromal Mesenchyme with p53 Loss in Response to Epithelial Tumorigenesis , 2005, Cell.

[15]  J. Vasiliev,et al.  Changes in p53 expression in mouse fibroblasts can modify motility and extracellular matrix organization , 2000, Oncogene.

[16]  Erwin G. Van Meir,et al.  Proteomic identification of the wt-p53-regulated tumor cell secretome , 2006, Oncogene.

[17]  N. B. Viana,et al.  Tenascin-C in the extracellular matrix promotes the selection of highly proliferative and tubulogenesis-defective endothelial cells. , 2011, Experimental cell research.

[18]  R. Poulsom,et al.  Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon , 2002, Gut.

[19]  P. Cirri,et al.  Cancer associated fibroblasts: the dark side of the coin. , 2011, American journal of cancer research.

[20]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[21]  A. Vaheri,et al.  Laminin is induced in astrocytes of adult brain by injury. , 1984, The EMBO journal.

[22]  G. Anderluh,et al.  Potentiation of anticancer-drug cytotoxicity by sea anemone pore-forming proteins in human glioblastoma cells , 2008, Anti-cancer drugs.

[23]  Jinsong Liu,et al.  Loss of p53 in stromal fibroblasts promotes epithelial cell invasion through redox-mediated ICAM1 signal. , 2013, Free radical biology & medicine.

[24]  Richard Beyer,et al.  TWIST1 promotes invasion through mesenchymal change in human glioblastoma , 2010, Molecular Cancer.

[25]  E. Holland,et al.  Astrocyte-Specific Expression Patterns Associated with the PDGF-Induced Glioma Microenvironment , 2012, PloS one.

[26]  D. Waisman,et al.  Exploitation of Astrocytes by Glioma Cells to Facilitate Invasiveness: A Mechanism Involving Matrix Metalloproteinase-2 and the Urokinase-Type Plasminogen Activator–Plasmin Cascade , 2003, The Journal of Neuroscience.

[27]  Darjus F. Tschaharganeh,et al.  Non-Cell-Autonomous Tumor Suppression by p53 , 2013, Cell.

[28]  S. Pluchino,et al.  Glioma-astrocyte interaction modifies the astrocyte phenotype in a co-culture experimental model. , 2009, Oncology reports.

[29]  R. Egan,et al.  Fibronectin immunoreactivity in neural trauma , 1991, Brain Research.

[30]  D. Schiffer,et al.  Cell proliferation and invasion in malignant gliomas. , 1997, Anticancer research.

[31]  Luciana Romão,et al.  Glioblastoma: therapeutic challenges, what lies ahead. , 2012, Biochimica et biophysica acta.

[32]  P. Platzer,et al.  Breast-cancer stromal cells with TP53 mutations and nodal metastases. , 2007, The New England journal of medicine.

[33]  M. Oren,et al.  The p53-Mdm2 module and the ubiquitin system. , 2003, Seminars in cancer biology.

[34]  D. Green,et al.  Cytoplasmic functions of the tumour suppressor p53 , 2009, Nature.

[35]  M. Neeman,et al.  Molecular and Cellular Pathobiology P53 Status in Stromal Fibroblasts Modulates Tumor Growth in an Sdf1-dependent Manner , 2022 .

[36]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[37]  T. Soussi.  p53 alterations in human cancer: more questions than answers , 2007, Oncogene.

[38]  M. Berens,et al.  The role of extracellular matrix in human astrocytoma migration and proliferation studied in a microliter scale assay , 1994, Clinical & Experimental Metastasis.

[39]  Margaret Ashcroft,et al.  Regulation of p53 stability , 1999, Oncogene.

[40]  Jerson L. Silva,et al.  The aggregation of mutant p53 produces prion-like properties in cancer , 2014, Prion.

[41]  Helmut Kettenmann,et al.  The brain tumor microenvironment , 2011, Glia.

[42]  G. Palmer,et al.  Cellular Migration and Invasion Uncoupled: Increased Migration Is Not an Inexorable Consequence of Epithelial-to-Mesenchymal Transition , 2014, Molecular and Cellular Biology.

[43]  S. Kahn,et al.  Microglial stress inducible protein 1 promotes proliferation and migration in human glioblastoma cells , 2012, Neuroscience.

[44]  J. Wang,et al.  Reduction of apoptosis in Rb-deficient embryos via Abl knockout , 2007, Oncogene.

[45]  P. Johnston,et al.  Cancer drug resistance: an evolving paradigm , 2013, Nature Reviews Cancer.

[46]  H. Kiaris,et al.  Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis. , 2005, Cancer research.

[47]  Valerie M. Weaver,et al.  The extracellular matrix at a glance , 2010, Journal of Cell Science.

[48]  V. Rotter,et al.  Cancer cells suppress p53 in adjacent fibroblasts , 2009, Oncogene.

[49]  E. Neilson,et al.  Biomarkers for epithelial-mesenchymal transitions. , 2009, The Journal of clinical investigation.

[50]  D. Figarella-Branger,et al.  Fibronectin expression in glioblastomas promotes cell cohesion, collective invasion of basement membrane in vitro and orthotopic tumor growth in mice , 2014, Oncogene.